We are led by an internationally experienced executive team with a proven track record
of success in managing pharmaceutical and medical device products through multiple
regulatory, pricing and reimbursement regimes.
Currently we employ around 50 staff worldwide.
Ian, our Chairman, has over 30 years of pharmaceutical industry experience, including founding Juno Pharmaceuticals Inc. He joined Contura in 2016 as Non-Executive Chairman. Ian was previously Chief Executive of Cobalt Pharmaceuticals (2000 – 2010) and was instrumental in the development of Arrow International business units. Ian’s other past roles include Executive VP of Genpharm Inc. and senior management roles at Amerpharm/Merck Generics, a division of Merck KGaA. Ian also worked in the office of the president of Par Pharmaceuticals (US).
Patrick has more than 20 years of experience running and growing life science companies. He has been Contura’s Chief Executive since 2010, and before that he was the company’s Chief Financial Officer. Prior to joining Contura Patrick was Chief Financial Officer at Inpharmatica Limited (2001 – 2007), a chemogenomics company, and Phairson Medical Limited (1996 – 2001), a protein therapeutics discovery company. Patrick is a Chartered Accountant by training and prior to his career in the life science sector he worked for 10 years in the financial markets practice of Arthur Andersen in London.
Rakesh has more than 20 years of experience in the pharmaceutical and medical device industry. Rakesh joined Contura as Vice President of Marketing in 2009. Rakesh was appointed UK General Manager of Contura in 2010 and General Manager, Northern Europe in 2013. In 2016 Rakesh was appointed to the Board position of Chief Operating Officer. Prior to his time at Contura, Rakesh spent five years at Takeda as EU Head of Specialty Products and held various roles in Corporate Development (2004 – 2009). Prior to this, Rakesh was at Pfizer as UK Marketing Manager (2003 – 2004), and before that at Pharmacia & Upjohn (1996 – 2003).
Graham brings more than 20 years of pharmaceutical industry experience to the company. He joined Contura in 2016 as a Non-Executive Director. Graham is Chief Executive of Aspire Pharma Limited, which he established in 2009. Aspire specialises in the licensing and marketing of both branded and generic medicines. Prior to establishing Aspire, Graham held sales and marketing roles with GSK and Dominion Pharma, and was Managing Director of Pliva Pharma UK.
Craig has over 15 years of pharmaceutical industry experience. Prior to co-founding Juno in 2011, Craig worked for Cobalt Pharmaceuticals in its business development group. He was responsible for negotiating product license and supply agreements for Cobalt’s OTC and generic divisions, and was Cobalt’s primary lead on all global M&A transactions.